Corrigendum to ‘A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer’ Eur J Cancer 2001, 37, S264–S265. R. Pirker, J. Vansteenkiste, J. Gateley, P. Yates, A. Colowick, J. Musil
Title:
Corrigendum to ‘A phase III, double-blind, placebo-controlled, randomized study of novel erythropoiesis stimulating protein (NESP) in patients undergoing platinum-treatment for lung cancer’ Eur J Cancer 2001, 37, S264–S265. R. Pirker, J. Vansteenkiste, J. Gateley, P. Yates, A. Colowick, J. Musil
Journal description